Aurinia Pharmaceuticals Inc. (AUPH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aurinia Pharmaceuticals I...

    NASDAQ: AUPH · Real-Time Price · USD
    12.40
    -0.13 (-1.04%)
    At close: Sep 05, 2025, 3:59 PM
    12.57
    1.37%
    Pre-market: Sep 08, 2025, 08:10 AM EDT

    Aurinia Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 235.13M 175.51M 134.03M 45.6M
    Cost of Revenue
    		 28.25M 14.15M 5.66M 1.09M
    Gross Profit
    		 206.88M 161.37M 128.37M 44.51M
    Operating Income
    		 -4.69M -91.69M -111.47M -180.74M
    Interest Income
    		 16.97M 17M 5.12M 529K
    Pretax Income
    		 7.45M -77.47M -106.35M -180.21M
    Net Income
    		 5.75M -78.02M -108.18M -180.97M
    Selling & General & Admin
    		 172.03M 195.04M 196.37M 171.44M
    Research & Development
    		 20.79M 49.64M 44.99M 51.14M
    Other Expenses
    		 18.76M 8.38M -1.52M 2.67M
    Operating Expenses
    		 211.57M 253.06M 239.84M 225.25M
    Interest Expense
    		 4.83M 2.77M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 239.82M 267.2M 245.5M 226.34M
    Income Tax Expense
    		 1.7M 551K 1.83M 760K
    Shares Outstanding (Basic)
    		 143.06M 143.24M 141.91M 129.37M
    Shares Outstanding (Diluted)
    		 146.19M 143.24M 141.91M 129.37M
    EPS (Basic)
    		 0.04 -0.54 -0.76 -1.4
    EPS (Diluted)
    		 0.04 -0.54 -0.76 -1.4
    EBITDA
    		 31.73M -63.05M -103.65M -177.44M
    EBIT
    		 12.28M -74.69M -106.35M -180.21M
    Depreciation & Amortization
    		 19.45M 11.65M 2.71M 2.76M

    Add to Watchlist